×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
XAIR – beyond air, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
XAIR
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/18
08:40 am
xair
Beyond Air (XAIR) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $10.00 price target on the stock.
Low
Report
Beyond Air (XAIR) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $10.00 price target on the stock.
3/17
05:14 pm
xair
Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial [Yahoo! Finance]
Low
Report
Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial [Yahoo! Finance]
3/17
04:35 pm
xair
Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial
Low
Report
Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial
3/11
07:37 am
xair
Beyond Air to Participate in the 38th Annual Roth Conference in March [Yahoo! Finance]
Low
Report
Beyond Air to Participate in the 38th Annual Roth Conference in March [Yahoo! Finance]
3/11
07:00 am
xair
Beyond Air to Participate in the 38th Annual Roth Conference in March
Low
Report
Beyond Air to Participate in the 38th Annual Roth Conference in March
3/10
11:50 am
xair
Beyond Air (XAIR) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $10.00 price target on the stock.
Low
Report
Beyond Air (XAIR) had its "buy" rating reaffirmed by D. Boral Capital. They now have a $10.00 price target on the stock.
3/10
08:01 am
xair
Beyond Air halts sale of NeuroNOS subsidiary to XTL Biopharmaceuticals [Seeking Alpha]
Medium
Report
Beyond Air halts sale of NeuroNOS subsidiary to XTL Biopharmaceuticals [Seeking Alpha]
3/10
07:30 am
xair
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.
Medium
Report
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/17
04:59 pm
xair
Form SCHEDULE 13G/A Beyond Air, Inc. Filed by: Alyeska Investment Group, L.P.
Low
Report
Form SCHEDULE 13G/A Beyond Air, Inc. Filed by: Alyeska Investment Group, L.P.
2/17
06:48 am
xair
Form SCHEDULE 13G/A Beyond Air, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
Low
Report
Form SCHEDULE 13G/A Beyond Air, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
2/13
04:16 pm
xair
Form 8-K Beyond Air, Inc. For: Feb 13
Low
Report
Form 8-K Beyond Air, Inc. For: Feb 13
2/13
04:02 pm
xair
Form 10-Q Beyond Air, Inc. For: Dec 31
Low
Report
Form 10-Q Beyond Air, Inc. For: Dec 31
2/2
04:06 pm
xair
Form 8-K Beyond Air, Inc. For: Jan 30
Neutral
Report
Form 8-K Beyond Air, Inc. For: Jan 30
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
Form SC 13G Beyond Air, Inc. Filed by: Mosseri Marlio Charles
21.4%
3/31 Form 8-K Beyond Air, Inc. For: Mar 31 16.7%
12/30 BeyondAirInc . (NASDAQ: XAIR) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 13.7%
2/28 BeyondAirInc . (NASDAQ: XAIR) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 13.4%
12/13 Hedge Funds Are Betting On Bellicum Pharmaceuticals Inc (BLCM) [Yahoo! Finance News] 11.4%
11/27 Form 8-K Beyond Air, Inc. For: Nov 25 10.9%
1/14 Form S-1 Beyond Air, Inc. 9.7%
10/22 Beyond Air™ to Attend the American Academy of Pediatrics (AAP) National Conference and Exhibition in New Orleans 7.2%
11/18 Form 4 Beyond Air, Inc. For: Nov 13 Filed by: BECK DOUGLAS 7.1%
10/24 Beyond Air™ Schedules Fiscal Second Quarter 2020 Financial Results Conference Call and Webcast 6.8%
3/31 Form 8-K Beyond Air, Inc. For: Mar 31 16.7%
12/30 BeyondAirInc . (NASDAQ: XAIR) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. 13.7%
2/28 BeyondAirInc . (NASDAQ: XAIR) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 13.4%
12/13 Hedge Funds Are Betting On Bellicum Pharmaceuticals Inc (BLCM) [Yahoo! Finance News] 11.4%
11/27 Form 8-K Beyond Air, Inc. For: Nov 25 10.9%
1/14 Form S-1 Beyond Air, Inc. 9.7%
10/22 Beyond Air™ to Attend the American Academy of Pediatrics (AAP) National Conference and Exhibition in New Orleans 7.2%
11/18 Form 4 Beyond Air, Inc. For: Nov 13 Filed by: BECK DOUGLAS 7.1%
10/24 Beyond Air™ Schedules Fiscal Second Quarter 2020 Financial Results Conference Call and Webcast 6.8%
TOP News Decliners
3/18
Form 8-K Beyond Air, Inc. For: Mar 16
-23.7%
3/5 Form 8-K Beyond Air, Inc. For: Mar 04 -18.7%
3/5 Beyond Air Hosting Analyst Day Today, March 5, 2020 at 2:00 p.m. ET -15.7%
12/9 Beyond Air Announces Proposed Public Offering and Concurrent Private Placement -12.3%
4/16 Beyond Air to Initiate Clinical Study Evaluating High Concentration Nitric Oxide for the Treatment of COVID-19 Patients in the United States -12.0%
2/25 Beyond Air Hosting Analyst Day on March 5, 2020 -11.7%
3/25 Form 424B3 Beyond Air, Inc. -9.1%
7/16 Form POS AM Beyond Air, Inc. -8.3%
4/16 Form 8-K Beyond Air, Inc. For: Apr 16 -7.4%
1/11 BeyondAirInc . (NASDAQ: XAIR) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -7.2%
3/5 Form 8-K Beyond Air, Inc. For: Mar 04 -18.7%
3/5 Beyond Air Hosting Analyst Day Today, March 5, 2020 at 2:00 p.m. ET -15.7%
12/9 Beyond Air Announces Proposed Public Offering and Concurrent Private Placement -12.3%
4/16 Beyond Air to Initiate Clinical Study Evaluating High Concentration Nitric Oxide for the Treatment of COVID-19 Patients in the United States -12.0%
2/25 Beyond Air Hosting Analyst Day on March 5, 2020 -11.7%
3/25 Form 424B3 Beyond Air, Inc. -9.1%
7/16 Form POS AM Beyond Air, Inc. -8.3%
4/16 Form 8-K Beyond Air, Inc. For: Apr 16 -7.4%
1/11 BeyondAirInc . (NASDAQ: XAIR) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -7.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: